Taurine prevents high glucose-induced angiopoietin-2/tie-2 system alterations and apoptosis in retinal microvascular pericytes

Molecular and Cellular Biochemistry

Volumn 396, Issue 1-2, 2014, Pages 239-248

  Zeng, Kaihong ^a   Ming, Jian ^b   Yang, Na ^a   Wang, Jing ^a   Yu, Xuemei ^a   Song, Yi ^a   Yang, Yongtao ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHWEST UNIVERSITY   (China)

Author keywords

Angiopoietin 2; Apoptosis; High glucose; Retinal microvascular pericytes; Taurine; Tie 2

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CASPASE 3; GLUCOSE; TAURINE;

ANIMAL; APOPTOSIS; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; PERICYTE; PHOSPHORYLATION; RETINA; SPRAGUE DAWLEY RAT;

ANGIOPOIETIN-2; ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; DOWN-REGULATION; GLUCOSE; PERICYTES; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; RECEPTOR, TIE-2; RETINA; TAURINE;

EID: 84907591751     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2159-3     Document Type: Article

References (45)

1. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115:1859-1868
2. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE, Sharrett AR, Shea S (2006) Diabetic retinopathy in a multi-ethniccohort in the United States. Am J Ophthalmol 141:446-455
3. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
4. Aiello LM (2003) Perspectives on diabetic retinopathy. Am J Ophthalmol 136:122-135
5. Klein BE, Klein R, Moss SE, Palta M (1995) A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 113:601-606
6. Pfister F, Feng Y, vom Hagen F, Hoffmann S, Molema G, Hillebrands JL, Shani M, Deutsch U, Hammes HP (2008) Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 57:2495-2502
7. Kim J (2004) Pericytes and the prevention of diabetic retinopathy. Diabetes Res Clin Pract 66:49-51
8. Kutcher ME, Kolyada AY, Surks HK, Herman IM (2007) Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state. Am J Pathol 171:693-701
9. Zou MH, Li H, He C, Lin M, Lyons TJ, Xie Z (2011) Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosisi-n diabetes. Am J Pathol 179:2835-2844
10. Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME (2008) The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopa-thy. Invest Ophthalmol Vis Sci 49:2163-2171
11. Takagi H, Koyama S, Seike H, Oh H, Otani A, Matsumura M, Honda Y (2003) Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci 4:393-402
12. Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, Daly R, Alitalo K, Dumont DJ (1999) Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274:30896-30905
13. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
14. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169
15. Puri MC, Bernstein A (2003) Requirement for the TIE family of receptortyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci USA 100:12753-12758
16. Park YS, Kim NH, Jo I (2003) Hypoxia and vascular endothelial growthfactor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovineretinal pericytes. Microvasc Res 65:125-131
17. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, aligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
18. Hammes HP, Lin J, Wagner P, Feng Y, vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U (2004) Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53:1104-1110
19. Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H (2005) Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 139:476-481
20. Pfister F, Wang Y, Schreiter K, vom Hagen F, Altvater K, Hoffmann S, Deutsch U, Hammes HP, Feng Y (2010) Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol 47:59-64
21. Feng Y, vom Hagen F, Pfister F, Djokic S, Hoffmann S, Back W, Wagner P, Lin J, Deutsch U, Hammes HP (2007) Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost 97:99-108
22. Rangasamy S, Srinivasan R, Maestas J, McGuire PG, Das A (2011) A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest Ophthalmol Vis Sci 52:3784-3791
23. Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ, Hsu CC, Faiman MD, Schloss JV, Wu JY (2001) Role of taurine in regulation of intracellular calcium level and neuroprotective function incult-ured neurons. J Neurosci Res 66:612-619
24. Di Leo MA, Santini SA, Cercone S, Lepore D, Silveri NG, Caputo S, Greco AV, Giardina B, Franconi F, Ghirlanda G (2002) Chronic taurine supplementation ameliorates oxidative stress and Na + K + ATPase impairment in the retina of diabetic rats. Amino Acids 23:401-406
25. Kaplan B, Karabay G, Zaʇyapan RD, Ozer C, Sayan H, Duyar I (2004) Effects of taurine in glucose and taurine administration. Amino Acids 27:327-333
26. Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330-346
27. Franconi F, Di Leo MA, Bennardini F, Ghirlanda G (2004) Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 29:143-150
28. Franconi F, Loizzo A, Ghirlanda G, Seghieri G (2006) Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care 9:32-36
29. Di Leo MA, Ghirlanda G, Silveri NG, Giardina B, Franconi F, Santini SA (2003) Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations. Free Radic Res 37:323-330
30. De Luca G, Calpona PR, Caponetti A, Romano G, Di Benedetto A, Cucinotta D, Di Giorgio RM (2001) Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients. Metabolism 50:60-64
31. Yu X, Xu Z, Mi M, Xu H, Zhu J, Wei N, Chen K, Zhang Q, Zeng K, Wang J, Chen F, Tang Y (2008) Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of gl-utamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res 33:500-507
32. Zeng K, Xu H, Mi M, Zhang Q, Zhang Y, Chen K, Chen F, Zhu J, Yu X (2009) Dietary taurine supplementation prevents glial alterations in retina of diabetic rats. Neurochem Res 34:244-254
33. Zeng K, Xu H, Chen K, Zhu J, Zhou Y, Zhang Q, Mantian M (2010) Effects of taurine on glutamate uptake and degradation in Müller cells under diabetic conditions via antioxidant mechanism. Mol Cell Neurosci 45:192-199
34. Zeng K, Xu H, Mi M, Chen K, Zhu J, Yi L, Zhang T, Zhang Q, Yu X (2010) Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under di-abetic conditions. Neurochem Res 35:1566-1574
35. Ueki I, Stipanuk MH (2007) Enzymes of the taurine biosynthetic pathway are expressed in rat mammary gland. J Nutr 137:1887-1894
36. Hayes KC, Rabin AR, Berson EL (1975) An ultrastructural study of nutritionally induced and reversed retinal degeneration in cats. Am J Pathol 78:505-524
37. Juen S, Kieselbach GF (1990) Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol 108:372-375
38. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy Penn State Retina Research Group. Diabetes 47:815-820
39. Barber AJ, Antonetti DA, Gardner TW (2000) Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabet-es. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 41:3561-3568
40. Bernardi N (1985) On the role of taurine in the cerebellar cortex: a reappraisal. Acta Physiol Pharmacol Latinoam 35:153-164
41. El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189-197
42. Thurston JH, Hauhart RE, Dirgo JA (1980) Taurine: a role in osmotic regulation of mammalian brain and possible clinical significance. Life Sci 26:1561-1568
43. Ohashi H, Takagi H, Koyama S, Oh H, Watanabe D, Antonetti DA, Matsubara T, Nagai K, Arai H, Kita T, Honda Y (2004) Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. Mol Vis 10:608-617
44. Alikhani M, Roy S, Graves DT (2010) FOXO1 plays an essential role in apoptosis of retinal pericytes. Mol Vis 16:408-415
45. Haribalaganesh R, Sheikpranbabu S, Elayappan B, Venkataraman D, Gurunatha S (2009) Pigment epithelium-derived factor down regulates hyperglycemia-induced apoptosis via PI3 K/Akt activationin goat retinal pericytes. Angiogenesis 2:381-389